A breast cancer research study now open at Baylor University Medical Center in Dallas is believed to be the first of its kind to explore the ability of new weight loss GIP/GLP-1 receptor agonists to combat breast cancer recurrence in overweight or obese pa
...
The US Army Medical Research and Development Command, a division of the Department of Defense, awarded a $2.7 million grant to Dr. Ann Marie Warren, PhD, ABPP, principal investigator for Baylor Scott & White Research Institute, to research prevent Post-tra
...
In collaboration with Exact Sciences, Baylor Scott & White Research Institute are now enrolling its first patients in the Texas Multi-Cancer Early Detection (MCED) Registry.
Baylor University Medical Center’s uterus transplant program—the largest of its kind in the world—published the results of an eight-year trial in JAMA, finding the procedure is safe and effective, resulting in a high rate of live births. The seminal study
...
The study results show exciting immune responses in patients with operable esophageal or gastroesophageal cancers given neoadjuvant immunotherapy and highlight the potential for monitoring circulating tumor DNA as a predictor for future intervention.
As the COVID-19 pandemic enters its third year, illness or disease caused by the SARS-Coronavirus-2 (SARS-CoV-2) infection continues to spread. As part of an effort to better understand COVID-19 infection prevention and transmission in children, Baylor Sco
...
Baylor Scott & White Glenda Tanner Vasicek Cancer Treatment Center (VCTC) – Temple opened a new radiation oncology facility that will benefit Central Texas cancer patients. Located on the Baylor Scott & White Medical Center – Temple campus, the two-story 2
...
